Kiji Therapeutics
Cell therapy development
- B2B
About Kiji Therapeutics
A biotech company in France and Spain, developing engineered cell therapies for life-threatening diseases targeting autoimmune diseases using gene-engineered iPSC derived MSC cells
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2023
- Revenue
- $3.2M – $25.3MTamtam estimate
- Website
- kiji-tx.com
Kiji Therapeutics at a glance
Kiji Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Kiji Therapeutics was founded in 2023.
Kiji Therapeutics has 1–10 employees.
Kiji Therapeutics's revenue is $3.2M – $25.3M (Tamtam estimate).
Frequently asked questions about Kiji Therapeutics
What is Kiji Therapeutics's revenue?
Tamtam estimates Kiji Therapeutics's annual revenue at $3.2M – $25.3M.
How many employees does Kiji Therapeutics have?
Kiji Therapeutics has 1–10 employees.
Where is Kiji Therapeutics headquartered?
Kiji Therapeutics is headquartered in Paris, Île-de-France, France.
Selling to companies like Kiji Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies